Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Crestor rosuvastatin: Phase III data

In the double-blind, international Phase III CORONA trial in 5,000 patients, 10 mg of Crestor plus existing medications

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE